Models Exposed

Published Sep 17, 2012
Princeton, NJ, USA – As consumers, we are becoming experts at scrutinizing the reviews our peers write about products we are thinking of buying. We ask ourselves if the comments written in the review truly fit the product, are the comments promotional or too negative, or simply unrelated to the product itself. Health care decision makers are starting to do this with modeling studies. They are asking themselves, “Where is this information coming from? Are the results realistic? Are they relevant to my decision?” Dr. Jaime Caro, co-author on the paper, “Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-7,” states, “For decision makers to trust the results of models, these must be shown to be valid in the sense of being sufficiently accurate and relevant. This subgroup of the ISPOR-SMDM Modeling Task Force detailed the steps required to ensure the validity of models and grappled with the difficult balance between transparency and protection of intellectual property, proposing a compromise that should provide for full scientific review of models.”  This paper provides guidance for health care researchers to ensure that their models are both transparent and valid. This paper is one of the seven papers in the series on modeling study best practices and is jointly published in Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and Medical Decision Making, the official journal of the Society for Medical Decision Making (SMDM).

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health. For more information: www.ispor.org

Related Stories

Promoting Fairness in Funding Decisions

Jun 24, 2026

Value in Health announced the publication of a special themed section of research papers that offer new tools to help health policy makers weigh fairness alongside cost-effectiveness when deciding which treatments and programs to fund.

Listening to Patients in the Real World

Jun 23, 2026

Value in Health, the official journal of ISPOR announced today the publication of an ISPOR Good Practices Report outlining 9 areas to strengthen the robustness, transparency, and feasibility of real-world patient-reported outcomes studies.

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×